Success Metrics

Clinical Success Rate

62.5%

Based on 5 completed trials

Completion Rate

63%(5/8)

Active Trials

1(11%)

Results Posted

140%(7 trials)

Terminated

3(33%)

Phase Distribution

Ph phase_2

11%

Ph phase_1

33%

Ph phase_4

11%

Ph phase_3

44%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

3(33.3%)

Phase 2Efficacy & side effects

1(11.1%)

Phase 3Large-scale testing

4(44.4%)

Phase 4Post-market surveillance

1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Terminated(3)

Detailed Status

Completed5

Terminated3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

62.5%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (33.3%)

Phase 21 (11.1%)

Phase 34 (44.4%)

Phase 41 (11.1%)

Trials by Status

completed556%

recruiting111%

terminated333%

Recent Activity

1 active trials

Showing 5 of 9

recruitingphase_1

Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

NCT07634770

completedphase_1

Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes

NCT01409239

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT07634770Phase 1

Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

Recruiting

NCT05441631Phase 1

Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients

Completed

NCT00812253Phase 2

Intensive Glycemic Control for Congestive Heart Failure Exacerbation

Completed

NCT00812487Phase 1

Glycemic Control and Variability for Congestive Heart Failure Exacerbation

Completed

NCT01409239Phase 4

Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes

Completed

NCT00139659Phase 3

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma

Completed

NCT00137046Phase 3

Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes

Terminated

NCT00136916Phase 3

Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes

Terminated

NCT00138671Phase 3

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Terminated

All 9 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 9